ATE170081T1 - Humane rotativen, impfstoffe und methoden - Google Patents

Humane rotativen, impfstoffe und methoden

Info

Publication number
ATE170081T1
ATE170081T1 AT92900590T AT92900590T ATE170081T1 AT E170081 T1 ATE170081 T1 AT E170081T1 AT 92900590 T AT92900590 T AT 92900590T AT 92900590 T AT92900590 T AT 92900590T AT E170081 T1 ATE170081 T1 AT E170081T1
Authority
AT
Austria
Prior art keywords
hrv
human
novel
rotaviruses
disclosed
Prior art date
Application number
AT92900590T
Other languages
English (en)
Inventor
Richard L Ward
Original Assignee
Childrens Hosp Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hosp Medical Center filed Critical Childrens Hosp Medical Center
Application granted granted Critical
Publication of ATE170081T1 publication Critical patent/ATE170081T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT92900590T 1990-11-16 1991-11-04 Humane rotativen, impfstoffe und methoden ATE170081T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61431090A 1990-11-16 1990-11-16

Publications (1)

Publication Number Publication Date
ATE170081T1 true ATE170081T1 (de) 1998-09-15

Family

ID=24460695

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92900590T ATE170081T1 (de) 1990-11-16 1991-11-04 Humane rotativen, impfstoffe und methoden

Country Status (13)

Country Link
US (2) US5474773A (de)
EP (1) EP0557427B1 (de)
JP (1) JP2753393B2 (de)
KR (1) KR0171434B1 (de)
AT (1) ATE170081T1 (de)
AU (2) AU9060391A (de)
BR (1) BR9106982A (de)
CA (1) CA2096315C (de)
DE (1) DE69130068T2 (de)
DK (1) DK0557427T3 (de)
ES (1) ES2121841T3 (de)
GR (1) GR3027744T3 (de)
WO (1) WO1992008786A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US5610049A (en) * 1991-05-01 1997-03-11 The Wistar Institute Of Anatomy And Biology Human rotavirus HCR3A and method of growing said rotavirus
US6780630B1 (en) * 1992-07-10 2004-08-24 Baylor College Of Medicine Parenteral immunization against rotavirus
US5773009A (en) * 1994-04-15 1998-06-30 The United States Of America As Represented By The Department Of Health And Human Services Rotavirus strain G9P11
WO1996001651A1 (en) * 1994-07-11 1996-01-25 The Government Of The United States Of America, Represented By The Department Of Health And Human Services Attenuated human rotavirus vaccine
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
CA2224697A1 (en) 1995-06-14 1997-01-03 Peng Tian Rotavirus enterotoxin nsp4 and methods of using same
EP0878541A4 (de) * 1996-10-18 2001-10-17 Univ Osaka Res Found Rotavirus-antigene, impfstoffe und medikamente gegen eine infektion durch rotaviren, sowie verfahren zu ihrer herstellung
US6589529B1 (en) 1998-10-30 2003-07-08 Children's Hospital Medical Center Rotavirus subunit vaccine
GB9919468D0 (en) 1999-08-17 1999-10-20 Smithkline Beecham Biolog Vaccine
SK287261B6 (sk) * 1999-08-17 2010-04-07 Smithkline Beecham Biologicals S.A. Oslabená ľudská rotavírusová populácia, spôsob jej výroby, vakcínový prostriedok s jej obsahom a jej použitie
KR100305188B1 (ko) * 2000-12-26 2001-09-24 정동혁 로타바이러스에 대한 백신
MXPA06002459A (es) * 2003-09-02 2006-06-20 Glaxosmithkline Biolog Sa Vacuna.
CN100448485C (zh) * 2003-09-02 2009-01-07 葛兰素史密丝克莱恩生物有限公司 疫苗
GB0414787D0 (en) * 2004-07-01 2004-08-04 Glaxosmithkline Biolog Sa Method
GB0503337D0 (en) 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
JP5519934B2 (ja) * 2005-08-17 2014-06-11 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 異型交差防御を誘導するロタウイルスワクチン
CA3121471A1 (en) 2009-05-12 2010-11-18 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention New human rotavirus strains and vaccines
PL3597757T3 (pl) 2012-05-11 2021-05-31 Medicago Inc. Wytwarzanie cząstek podobnych do rotawirusów w roślinach
JP6841762B2 (ja) 2015-01-23 2021-03-10 メディカゴ インコーポレイテッド 植物中でのロタウイルス様粒子産生
GB201614799D0 (en) 2016-09-01 2016-10-19 Glaxosmithkline Biologicals Sa Compositions
CN117737005B (zh) * 2024-01-31 2024-05-14 金宇保灵生物药品有限公司 一株猪轮状病毒毒株及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341870A (en) * 1980-11-19 1982-07-27 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Cultivatable human rotavirus type 2
US4341763A (en) * 1981-03-10 1982-07-27 Smithkline-Rit Methods of vaccinating humans against rotavirus infection
US4571385A (en) * 1983-06-27 1986-02-18 The United States Of America As Represented By The Department Of Health And Human Services Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors
EP0152295B1 (de) * 1984-02-09 1991-03-20 Royal Children's Hospital Research Foundation Lebender attenuierter menschlicher Rotavirus-Impfstoff und Herstellung desselben
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
US4853333A (en) * 1985-07-26 1989-08-01 American Home Products Corporation Production of rotavirus in yeast
US4751080A (en) * 1985-08-26 1988-06-14 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against rotavirus diseases
US4927628A (en) * 1987-09-21 1990-05-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against rotavirus diseases and method of preparing same
WO1989006971A1 (en) * 1988-02-01 1989-08-10 The Board Of Trustees Of The Leland Stanford Junio Conserved rotavirus gene segments and use in immunization and neutralization

Also Published As

Publication number Publication date
AU702044B2 (en) 1999-02-11
DK0557427T3 (da) 1998-10-26
EP0557427A4 (de) 1995-01-25
CA2096315C (en) 1996-11-19
AU9060391A (en) 1992-06-11
US5474773A (en) 1995-12-12
JP2753393B2 (ja) 1998-05-20
CA2096315A1 (fr) 1992-05-17
KR0171434B1 (ko) 1999-02-01
EP0557427A1 (de) 1993-09-01
JPH06505964A (ja) 1994-07-07
US5695767A (en) 1997-12-09
WO1992008786A1 (en) 1992-05-29
DE69130068T2 (de) 1999-01-07
ES2121841T3 (es) 1998-12-16
DE69130068D1 (de) 1998-10-01
AU3787795A (en) 1996-02-29
BR9106982A (pt) 1993-08-31
EP0557427B1 (de) 1998-08-26
GR3027744T3 (en) 1998-11-30

Similar Documents

Publication Publication Date Title
DE69130068D1 (de) Humane rotativen, impfstoffe und methoden
Fekadu et al. Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses
DK0755259T3 (da) Kimære-cDNA-kloner af virussen for den infektiöse GUMBORO-syge, ekspressionsprodukter heraf og vacciner baseret derpå
DE69026975T2 (de) Impfstoff gegen Coccidiosis
JP2004529854A (ja) 増殖性回腸炎のための改善されたワクチン及びその作製と使用の方法
DE2967036D1 (en) Vaccine and method of making
Paul et al. Immunogens of rotaviruses
DE69030099T2 (de) Verfahren zur herstellung von impfstoffen oder toxoiden
DK167599B1 (da) Vaccine til beskyttelse af heste mod kvaerke foraarsaget af streptococcus equi, fremgangsmaade til fremstilling af en stamme af s. equi, som er avirulent for heste, samt s. equi-stamme
ATE285791T1 (de) Impfstoff, der acemannan als adjuvans enthält
DE3854575T2 (de) Reassortantes Rotavirusvakzin.
US3962422A (en) Method for immunizing nursing piglets against transmissible gastroenteritis(TGE) virus
DE69130206T2 (de) Impfstoff aus reassortiertem rotavirus
US5632989A (en) Attenuated, live vaccine for Delaware strain IBDV
Ward Human rotaviruses, vaccines and method
DK170393B1 (da) Avirulent rabies-vaccine samt avirulent mutant af stammen SAD Berne
Flores et al. Molecular cloning of rotaviral genes: Implications for immunoprophylaxis.
EKUE EPIDEMIOLOGY OF AFRICAN SWINE FEVER IN CAMEROON (SWINE FEVER)
Hyllseth et al. Cross Neutralization of Maedi‐Visna Virus Strains
Cunningham AVIAN INFECTIOUS BRONCHITIS: PATHOBIOLOGY AND IMMUNITY
RU94023834A (ru) Штамм гриба trichophyton verrucosum, используемый для изготовления вакцины против дерматофитозов животных

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time